The global hemophilia treatment is expected to reach US$ 44,089.71 Mn in 2027 from US$ 14,454.81 Mn in 2019. The market is estimated to grow with a CAGR of 15.9% from 2020-2027.
The growth of the hemophilia treatment is primarily attributed to the factors such as increasing prevalence of hemophilia and rise in favorable government initiatives leading to launch of new products in the market. However, high cost related with hemophilia treatment is likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global hemophilia treatment during the forecast period.
Hemophilia is a hereditary bleeding disorder that stops the blood from clotting normally. The primary symptom is uncontrolled, often spontaneous bleeding in different areas of the body. According to data from the National Hemophilia Foundation in 2020, Hemophilia A happens in 1 in 5,000 live male births. Hemophilia A is about four times as common as hemophilia B. The number of people with hemophilia in the United States is anticipated to be around 20,000 individuals. Moreover, the incidence of hemophilia is not known across the globe but projected at above 400,000 people. Almost 75% of people with hemophilia worldwide are either undiagnosed or receive disparate treatment.
In Italy, according to the data of the National Center for Biotechnology Information (NCBI) in 2017, the number of registered people with bleeding disorders increased from about 7000 in 2000 to around 8500 in 2011 and more than 11,000 in 2015. The trend is due to an upsurge in the number of patients who are recorded, mainly in those with vWD type 1, mild hemophilia, or other factor deficiencies. Thus, increasing prevalence of hemophilia, high cases of under-diagnosed hemophilia cases, and improving healthcare infrastructure will eventually grow the market for hemophilia treatment in the forecast period.
Global hemophilia treatment, based on the product, is segmented into plasma derived coagulation factor concentrates plasma derived coagulation factor concentrates, desmopressin, antifibrinolytic agents. In 2019, the recombinant coagulation factor concentrates held the largest share of the market, by product. Also, recombinant coagulation factor concentrates segment is expected to grow at the fastest rate during the coming years owing to increasing adoption of integrated systems across the globe.
Some of the major primary and secondary sources for Hemostats included in the report are Centers for Disease Control and Prevention (CDC), USFDA, Central Intelligence Agency (CIA), National Clinical Database, and others.
Reasons to Buy:
The growth of the hemophilia treatment is primarily attributed to the factors such as increasing prevalence of hemophilia and rise in favorable government initiatives leading to launch of new products in the market. However, high cost related with hemophilia treatment is likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global hemophilia treatment during the forecast period.
Hemophilia is a hereditary bleeding disorder that stops the blood from clotting normally. The primary symptom is uncontrolled, often spontaneous bleeding in different areas of the body. According to data from the National Hemophilia Foundation in 2020, Hemophilia A happens in 1 in 5,000 live male births. Hemophilia A is about four times as common as hemophilia B. The number of people with hemophilia in the United States is anticipated to be around 20,000 individuals. Moreover, the incidence of hemophilia is not known across the globe but projected at above 400,000 people. Almost 75% of people with hemophilia worldwide are either undiagnosed or receive disparate treatment.
In Italy, according to the data of the National Center for Biotechnology Information (NCBI) in 2017, the number of registered people with bleeding disorders increased from about 7000 in 2000 to around 8500 in 2011 and more than 11,000 in 2015. The trend is due to an upsurge in the number of patients who are recorded, mainly in those with vWD type 1, mild hemophilia, or other factor deficiencies. Thus, increasing prevalence of hemophilia, high cases of under-diagnosed hemophilia cases, and improving healthcare infrastructure will eventually grow the market for hemophilia treatment in the forecast period.
Global hemophilia treatment, based on the product, is segmented into plasma derived coagulation factor concentrates plasma derived coagulation factor concentrates, desmopressin, antifibrinolytic agents. In 2019, the recombinant coagulation factor concentrates held the largest share of the market, by product. Also, recombinant coagulation factor concentrates segment is expected to grow at the fastest rate during the coming years owing to increasing adoption of integrated systems across the globe.
Some of the major primary and secondary sources for Hemostats included in the report are Centers for Disease Control and Prevention (CDC), USFDA, Central Intelligence Agency (CIA), National Clinical Database, and others.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hemophilia treatment.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global hemophilia treatment, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Hemophilia Treatment Market - By Product
1.3.2 Global Hemophilia Treatment Market - By Disease
1.3.3 Global Hemophilia Treatment Market - By Treatment Type
1.3.4 Global Hemophilia Treatment Market - By Therapy
1.3.5 Global Hemophilia Treatment Market - By End User
1.3.6 Global Hemophilia Treatment Market - By Geography
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Hemophilia Treatment Market - By Product
1.3.2 Global Hemophilia Treatment Market - By Disease
1.3.3 Global Hemophilia Treatment Market - By Treatment Type
1.3.4 Global Hemophilia Treatment Market - By Therapy
1.3.5 Global Hemophilia Treatment Market - By End User
1.3.6 Global Hemophilia Treatment Market - By Geography
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
3.2 Secondary Research
3.3 Primary Research
4. Hemophilia Treatment- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 APAC: PEST Analysis
4.2.4 MEA: PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 APAC: PEST Analysis
4.2.4 MEA: PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Hemophilia Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Hemophilia
5.1.2 Rise in Favorable Government Initiatives
5.2 Market Restraints
5.2.1 High Cost Related with Hemophilia Treatment
5.3 Market Opportunities
5.3.1 Growth in the Global Healthcare Market
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
5.1.1 Increasing Prevalence of Hemophilia
5.1.2 Rise in Favorable Government Initiatives
5.2 Market Restraints
5.2.1 High Cost Related with Hemophilia Treatment
5.3 Market Opportunities
5.3.1 Growth in the Global Healthcare Market
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. Hemophilia Treatment Market - Global Analysis
6.1 Global Hemophilia Treatment Market Revenue Forecast And Analysis
6.2 Global Hemophilia Treatment Market, By Geography - Forecast And Analysis
6.3 Positioning of Key Players
6.3.1 Bayer AG
6.3.2 Pfizer Inc.
6.2 Global Hemophilia Treatment Market, By Geography - Forecast And Analysis
6.3 Positioning of Key Players
6.3.1 Bayer AG
6.3.2 Pfizer Inc.
7. Global Hemophilia Treatment Market Analysis- by Product
7.1 Overview
7.2 Hemophilia Treatment Market Revenue Share, by Product (2019 and 2027)
7.3 Plasma-Derived Coagulation Factor Concentrates
7.3.1 Overview
7.3.2 Plasma-Derived Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Factor VIII
7.3.3.1 Overview
7.3.3.2 Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Factor IX
7.3.4.1 Overview
7.3.4.2 Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Factor XII
7.3.5.1 Overview
7.3.5.2 Factor XII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Activated Prothrombin Complex Concentrates
7.3.6.1 Overview
7.3.6.2 Activated Prothrombin Complex Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.7 Von Willebrand Factor
7.3.7.1 Overview
7.3.7.2 Von Willebrand Factor: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Recombinant Coagulation Factor Concentrates
7.4.1 Overview
7.4.2 Recombinant Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Factor VIII
7.4.3.1 Overview
7.4.3.2 Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Factor IX
7.4.4.1 Overview
7.4.4.2 Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Desmopressin
7.5.1 Overview
7.5.2 Desmopressin: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antifibrinolytic Agents
7.6.1 Overview
7.6.2 Antifibrinolytic Agents: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.2 Hemophilia Treatment Market Revenue Share, by Product (2019 and 2027)
7.3 Plasma-Derived Coagulation Factor Concentrates
7.3.1 Overview
7.3.2 Plasma-Derived Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Factor VIII
7.3.3.1 Overview
7.3.3.2 Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Factor IX
7.3.4.1 Overview
7.3.4.2 Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Factor XII
7.3.5.1 Overview
7.3.5.2 Factor XII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Activated Prothrombin Complex Concentrates
7.3.6.1 Overview
7.3.6.2 Activated Prothrombin Complex Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.3.7 Von Willebrand Factor
7.3.7.1 Overview
7.3.7.2 Von Willebrand Factor: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Recombinant Coagulation Factor Concentrates
7.4.1 Overview
7.4.2 Recombinant Coagulation Factor Concentrates: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Factor VIII
7.4.3.1 Overview
7.4.3.2 Factor VIII: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Factor IX
7.4.4.1 Overview
7.4.4.2 Factor IX: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Desmopressin
7.5.1 Overview
7.5.2 Desmopressin: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antifibrinolytic Agents
7.6.1 Overview
7.6.2 Antifibrinolytic Agents: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8. Hemophilia Treatment Market Analysis- by Disease
8.1 Overview
8.2 Hemophilia Treatment Market, by Disease 2019 and 2027 (%)
8.3 Hemophilia A
8.3.1 Overview
8.3.2 Hemophilia A: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Hemophilia B
8.4.1 Overview
8.4.2 Hemophilia B: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Hemophilia C
8.5.1 Overview
8.5.2 Hemophilia C: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.2 Hemophilia Treatment Market, by Disease 2019 and 2027 (%)
8.3 Hemophilia A
8.3.1 Overview
8.3.2 Hemophilia A: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Hemophilia B
8.4.1 Overview
8.4.2 Hemophilia B: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Hemophilia C
8.5.1 Overview
8.5.2 Hemophilia C: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9. Hemophilia Treatment Market Analysis - by Treatment Type
9.1 Overview
9.2 Hemophilia Treatment Market Revenue Share, by Treatment Type (2019 and 2027)
9.3 Prophylaxis
9.3.1 Overview
9.3.2 Prophylaxis: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.4 On-demand
9.4.1 Overview
9.4.2 On-demand: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.2 Hemophilia Treatment Market Revenue Share, by Treatment Type (2019 and 2027)
9.3 Prophylaxis
9.3.1 Overview
9.3.2 Prophylaxis: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
9.4 On-demand
9.4.1 Overview
9.4.2 On-demand: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10. Hemophilia Treatment Market Analysis- by Therapy
10.1 Overview
10.2 Hemophilia Treatment Market, by Therapy 2019 and 2027 (%)
10.3 Replacement Therapy
10.3.1 Overview
10.3.2 Replacement Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10.4 ITI Therapy
10.4.1 Overview
10.4.2 ITI Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Gene Therapy
10.5.1 Overview
10.5.2 Gene Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10.2 Hemophilia Treatment Market, by Therapy 2019 and 2027 (%)
10.3 Replacement Therapy
10.3.1 Overview
10.3.2 Replacement Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10.4 ITI Therapy
10.4.1 Overview
10.4.2 ITI Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Gene Therapy
10.5.1 Overview
10.5.2 Gene Therapy: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11. Hemophilia Treatment Market Analysis- by End User
11.1 Overview
11.2 Hemophilia Treatment Market, by End User 2019 and 2027 (%)
11.3 Hospitals & Clinics
11.3.1 Overview
11.3.2 Hospitals & Clinics: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Hemophilia Treatment Centers
11.4.1 Overview
11.4.2 Hemophilia Treatment Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Ambulatory Surgical Centers
11.5.1 Overview
11.5.2 Ambulatory Surgical Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.2 Hemophilia Treatment Market, by End User 2019 and 2027 (%)
11.3 Hospitals & Clinics
11.3.1 Overview
11.3.2 Hospitals & Clinics: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Hemophilia Treatment Centers
11.4.1 Overview
11.4.2 Hemophilia Treatment Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Ambulatory Surgical Centers
11.5.1 Overview
11.5.2 Ambulatory Surgical Centers: Hemophilia Treatment Market - Revenue and Forecast to 2027 (US$ Million)
12. Hemophilia Treatment Market - Geographic Analysis
12.1 North America: Hemophilia Treatment Market
12.1.1 North America Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.2 North America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.2.1 North America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.2.2 North America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.3 North America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.4 North America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.5 North America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.6 North America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.7 North America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.1.8 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.8.1 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.8.2 US Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.8.2.1 US Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.8.2.2 US Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.8.3 US Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.8.4 US Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.8.5 US Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.8.6 US Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.9 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.9.1 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.9.2 Canada Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.9.2.1 Canada Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.2.2 Canada Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.3 Canada Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.9.4 Canada Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.5 Canada Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.9.6 Canada Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.10 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.10.1 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.10.2 Mexico Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.10.2.1 Mexico Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.2.2 Mexico Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Mexico Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.10.4 Mexico Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Mexico Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Mexico Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2 Europe: Hemophilia Treatment Market
12.2.1 Overview
12.2.2 Europe Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.3 Europe Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.3.1 Europe Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.3.2 Europe Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.4 Europe Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.5 Europe Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.6 Europe Hemophilia Treatment Market, by Therapy- Revenue and Forecast to 2027 (USD Million)
12.2.7 Europe Hemophilia Treatment Market, by End User- Revenue and Forecast to 2027 (USD Million)
12.2.8 Europe Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.2.9 Germany Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.9.1 Germany Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.9.2 Germany Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.9.2.1 Germany Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.2.2 Germany Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.3 Germany Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.9.4 Germany Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.5 Germany Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.9.6 Germany Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.10 UK Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.10.1 UK Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.10.2 UK Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.10.2.1 UK Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.2.2 UK Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.3 UK Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.10.4 UK Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.5 UK Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.10.6 UK Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.11 France Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.11.1 France Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.11.2 France Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.11.2.1 France Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.2.2 France Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.3 France Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.11.4 France Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.5 France Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.11.6 France Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.12 Spain Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.12.1 Spain Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.12.2 Spain Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.12.2.1 Spain Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.2.2 Spain Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.3 Spain Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.12.4 Spain Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.5 Spain Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.12.6 Spain Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.13 Italy Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.13.1 Italy Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.13.2 Italy Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.13.2.1 Italy Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.2.2 Italy Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.3 Italy Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.13.4 Italy Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.5 Italy Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.13.6 Italy Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3 APAC: Hemophilia Treatment Market
12.3.1 Asia Pacific Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.3.2 Asia Pacific Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.2.1 Asia Pacific Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.2.2 Asia Pacific Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.3 Asia Pacific Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.4 Asia Pacific Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.5 Asia Pacific Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.6 Asia Pacific Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.7 Asia Pacific Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.3.8 Japan
12.3.8.1 Japan Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.8.2 Japan Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.8.2.1 Japan Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.8.2.2 Japan Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.8.3 Japan Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.8.4 Japan Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.8.5 Japan Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.8.6 Japan Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.9 China
12.3.9.1 China Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.9.2 China Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.9.2.1 China Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.9.2.2 China Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.9.3 China Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.9.4 China Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.9.5 China Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.9.6 China Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.10 India
12.3.10.1 India Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.10.2 India Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.10.2.1 India Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.10.2.2 India Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.10.3 India Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.10.4 India Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.10.5 India Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.10.6 India Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.11 South Korea
12.3.11.1 South Korea Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.11.2 South Korea Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.11.2.1 South Korea Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.11.2.2 South Korea Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.11.3 South Korea Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.11.4 South Korea Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.11.5 South Korea Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.11.6 South Korea Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.12 Australia
12.3.12.1 Australia Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.12.2 Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
12.3.12.2.1 Australia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.12.2.2 Australia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.12.3 Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
12.3.12.4 Australia Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.12.5 Australia Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.12.6 Australia Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4 Middle East & Africa: Hemophilia Treatment Market
12.4.1 Overview
12.4.2 Middle East & Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.3 Middle East & Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.4.3.1 Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.3.2 Middle East & Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.4 Middle East & Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.5 Middle East & Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.6 Middle East & Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.7 Middle East & Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4.8 Middle East & Africa Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.4.9 Saudi Arabia
12.4.9.1 Saudi Arabia Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.9.2 Saudi Arabia Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.4.9.2.1 Saudi Arabia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.9.2.2 Saudi Arabia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.9.3 Saudi Arabia Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.9.4 Saudi Arabia Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.9.5 Saudi Arabia Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.9.6 Saudi Arabia Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4.10 UAE
12.4.10.1 UAE Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.10.1.1 UAE Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.10.1.2 UAE Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.10.2 UAE Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.10.3 UAE Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.10.4 UAE Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.10.5 UAE Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4.11 South Africa
12.4.11.1 South Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.11.2 South Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.4.11.2.1 South Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.11.2.2 South Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.11.3 South Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.11.4 South Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.11.5 South Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.11.6 South Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.5 South And Central America: Hemophilia Treatment Market
12.5.1 South and Central America Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.5.2 South and Central America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.5.2.1 South and Central America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.2.2 South and Central America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.3 South and Central America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.5.4 South and Central America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.5.5 South and Central America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.5.6 South and Central America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.5.7 South and Central America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.5.8 Brazil
12.5.8.1 Brazil Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.5.8.2 Brazil Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.5.8.2.1 Brazil Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.8.2.2 Brazil Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.8.3 Brazil Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.5.8.4 Brazil Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.5.8.5 Brazil Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.5.8.6 Brazil Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.5.9 Argentina
12.5.9.1 Argentina Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.5.9.2 Argentina Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.5.9.2.1 Argentina Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.9.2.2 Argentina Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.9.3 Argentina Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.5.9.4 Argentina Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.5.9.5 Argentina Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.5.9.6 Argentina Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.1 North America Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.2 North America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.2.1 North America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.2.2 North America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.3 North America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.4 North America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.5 North America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.6 North America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.7 North America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.1.8 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.8.1 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.8.2 US Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.8.2.1 US Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.8.2.2 US Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.8.3 US Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.8.4 US Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.8.5 US Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.8.6 US Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.9 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.9.1 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.9.2 Canada Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.9.2.1 Canada Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.2.2 Canada Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.3 Canada Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.9.4 Canada Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.5 Canada Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.9.6 Canada Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.1.10 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.10.1 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.10.2 Mexico Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.10.2.1 Mexico Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.2.2 Mexico Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Mexico Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.1.10.4 Mexico Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Mexico Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Mexico Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2 Europe: Hemophilia Treatment Market
12.2.1 Overview
12.2.2 Europe Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.3 Europe Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.3.1 Europe Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.3.2 Europe Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.4 Europe Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.5 Europe Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.6 Europe Hemophilia Treatment Market, by Therapy- Revenue and Forecast to 2027 (USD Million)
12.2.7 Europe Hemophilia Treatment Market, by End User- Revenue and Forecast to 2027 (USD Million)
12.2.8 Europe Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.2.9 Germany Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.9.1 Germany Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.9.2 Germany Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.9.2.1 Germany Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.2.2 Germany Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.3 Germany Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.9.4 Germany Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.5 Germany Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.9.6 Germany Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.10 UK Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.10.1 UK Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.10.2 UK Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.10.2.1 UK Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.2.2 UK Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.3 UK Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.10.4 UK Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.5 UK Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.10.6 UK Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.11 France Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.11.1 France Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.11.2 France Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.11.2.1 France Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.2.2 France Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.3 France Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.11.4 France Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.5 France Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.11.6 France Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.12 Spain Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.12.1 Spain Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.12.2 Spain Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.12.2.1 Spain Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.2.2 Spain Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.3 Spain Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.12.4 Spain Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.5 Spain Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.12.6 Spain Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.2.13 Italy Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.2.13.1 Italy Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.2.13.2 Italy Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.13.2.1 Italy Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.2.2 Italy Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.3 Italy Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.2.13.4 Italy Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.5 Italy Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.2.13.6 Italy Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3 APAC: Hemophilia Treatment Market
12.3.1 Asia Pacific Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.3.2 Asia Pacific Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.2.1 Asia Pacific Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.2.2 Asia Pacific Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.3 Asia Pacific Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.4 Asia Pacific Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.5 Asia Pacific Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.6 Asia Pacific Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.7 Asia Pacific Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.3.8 Japan
12.3.8.1 Japan Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.8.2 Japan Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.8.2.1 Japan Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.8.2.2 Japan Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.8.3 Japan Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.8.4 Japan Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.8.5 Japan Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.8.6 Japan Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.9 China
12.3.9.1 China Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.9.2 China Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.9.2.1 China Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.9.2.2 China Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.9.3 China Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.9.4 China Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.9.5 China Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.9.6 China Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.10 India
12.3.10.1 India Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.10.2 India Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.10.2.1 India Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.10.2.2 India Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.10.3 India Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.10.4 India Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.10.5 India Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.10.6 India Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.11 South Korea
12.3.11.1 South Korea Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.11.2 South Korea Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.3.11.2.1 South Korea Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.11.2.2 South Korea Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.11.3 South Korea Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.3.11.4 South Korea Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.11.5 South Korea Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.11.6 South Korea Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.3.12 Australia
12.3.12.1 Australia Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.3.12.2 Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
12.3.12.2.1 Australia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.12.2.2 Australia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.3.12.3 Australia Hemophilia Treatment Market, by Disease- Revenue and Forecast to 2027 (USD Million)
12.3.12.4 Australia Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.3.12.5 Australia Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.3.12.6 Australia Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4 Middle East & Africa: Hemophilia Treatment Market
12.4.1 Overview
12.4.2 Middle East & Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.3 Middle East & Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.4.3.1 Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.3.2 Middle East & Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.4 Middle East & Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.5 Middle East & Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.6 Middle East & Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.7 Middle East & Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4.8 Middle East & Africa Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.4.9 Saudi Arabia
12.4.9.1 Saudi Arabia Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.9.2 Saudi Arabia Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.4.9.2.1 Saudi Arabia Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.9.2.2 Saudi Arabia Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.9.3 Saudi Arabia Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.9.4 Saudi Arabia Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.9.5 Saudi Arabia Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.9.6 Saudi Arabia Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4.10 UAE
12.4.10.1 UAE Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.10.1.1 UAE Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.10.1.2 UAE Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.10.2 UAE Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.10.3 UAE Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.10.4 UAE Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.10.5 UAE Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.4.11 South Africa
12.4.11.1 South Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.4.11.2 South Africa Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.4.11.2.1 South Africa Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.11.2.2 South Africa Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.4.11.3 South Africa Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.4.11.4 South Africa Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.4.11.5 South Africa Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.4.11.6 South Africa Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.5 South And Central America: Hemophilia Treatment Market
12.5.1 South and Central America Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
12.5.2 South and Central America Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.5.2.1 South and Central America Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.2.2 South and Central America Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.3 South and Central America Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.5.4 South and Central America Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.5.5 South and Central America Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.5.6 South and Central America Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.5.7 South and Central America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
12.5.8 Brazil
12.5.8.1 Brazil Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.5.8.2 Brazil Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.5.8.2.1 Brazil Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.8.2.2 Brazil Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.8.3 Brazil Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.5.8.4 Brazil Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.5.8.5 Brazil Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.5.8.6 Brazil Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
12.5.9 Argentina
12.5.9.1 Argentina Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
12.5.9.2 Argentina Hemophilia Treatment Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.5.9.2.1 Argentina Plasma Derived Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.9.2.2 Argentina Recombinant Coagulation Factor Concentrates Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.5.9.3 Argentina Hemophilia Treatment Market, by Disease - Revenue and Forecast to 2027 (USD Million)
12.5.9.4 Argentina Hemophilia Treatment Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
12.5.9.5 Argentina Hemophilia Treatment Market, by Therapy - Revenue and Forecast to 2027 (USD Million)
12.5.9.6 Argentina Hemophilia Treatment Market, by End User - Revenue and Forecast to 2027 (USD Million)
13. Global Hemophilia Treatment Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done By the Companies in the Market, (%)
13.3 Organic Developments Done By The Companies in The Market
13.4 Inorganic Developments Done by The Companies In The Market
13.2 Growth Strategies Done By the Companies in the Market, (%)
13.3 Organic Developments Done By The Companies in The Market
13.4 Inorganic Developments Done by The Companies In The Market
14. COMPANY PROFILES
14.1 Bayer AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. Hoffmann-La Roche Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Kedrion S.p.A
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CSL Limited
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biotest AG.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Novo Nordisk A/S
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Octapharma AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Baxter International Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. Hoffmann-La Roche Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Kedrion S.p.A
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CSL Limited
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biotest AG.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Novo Nordisk A/S
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Octapharma AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Baxter International Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
15.2 Glossary of Terms
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Sanofi
- F. Hoffmann-la Roche Ltd.
- Kedrion S.P.A.
- CSL Limited
- Biotest AG
- Pfizer Inc.
- Novo Nordisk A/S
- Octapharma AG
- Baxter International Inc
